Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Wegovy Benefits Heart Disease Patients Regardless of Frailty

(MedPage Today) -- Frailty did not appear to prevent adults with cardiovascular disease and overweight or obesity from reaping the benefits of semaglutide (Wegovy), a secondary analysis of SELECT trial data indicated. By week 104, semaglutide...

Wegovy Benefits Heart Disease Patients Regardless of Frailty

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

Ros Chown obituary

My wife, Ros Chown, who has died aged 71, spent most of her working career as a sexual health adviser (SHA) in genito-urinary medicine in Cambridge, Wakefield and Torbay.

More from Friday 18 September →